Our team of experts tirelessly develops and validates new Anti-AAV ELISA kits as listed below for anti-AAV antibody screening, specifically designed to detect anti-AAV serotype antibodies under high-stringency conditions in the serum/plasma of humans, monkeys, minipigs, and other species with high sensitivity, simplicity, and specificity. We utilize state-of-the-art technology and cutting-edge research techniques to create these test kits for preclinical and clinical research. Additionally, we can collaborate with CLIA Lab to develop lab-developed kits and Companion Diagnostics kits. Our Anti-AAV antibody ELISA kits include serotypes AAV1, 2, 5, 6, 8, 9, rh74, or custom-provided AAV variant vectors, and we also offer ddPCR services to enhance your research capabilities.
We have developed MSD bridging-based AAV antibody assays for anti-AAV antibody screening across AAV1, 2, 5, 6, 8, 9, and rh74 serotypes. Additionally, we offer Anti-AAV ELISA kits and ddPCR services to support your research needs. Refer to our publication 2 below.
We have developed Chemiluminescence Bridging-based anti-AAV antibody assays for AAV1, 2, 5, 6, 8, 9, and rh74 serotypes, which can also be used for anti-AAV antibody screening.
We have developed cell-based anti-AAV neutralizing antibody assays for AAV1, 2, 5, 6, 8, 9, and rh74 serotypes, which are used for anti-AAV neutralizing antibody screening.
Our team specializes in ddPCR services to develop assays that quantify gene expression, alongside a Replication-Competency assay for cell and gene therapies targeting a variety of diseases.
We are focused on developing the ELISpot assay to detect T cell immunity, which is essential for advancing gene and cell therapy.
We utilize Stunner from Unchained Labs to detect AAV vector titer, identify empty/full AAV vectors, and evaluate AAV vector aggregation.